No Data
Express News | [Significant Shareholding Report] Sparks Asset Management reports a 5.16% Shareholding in Sasmmed (4263.JP).
Stock News Premium = Expanding support for "painless childbirth" creates business opportunities related to childbirth.
It has been reported that Tokyo is planning to subsidize the costs of painless childbirth ('無痛分娩'). There is also a possibility that similar movements will spread, potentially benefiting related stocks. <The city will provide a subsidy of 100,000 yen> Painless childbirth, which alleviates the pain of labor through anesthesia and other methods, is spreading in Europe and the United States as a means to reduce maternal fatigue and stress. In Japan, it is becoming more common as a method that minimizes labor pain, accounting for over 10% of all deliveries in 2022. Meanwhile, currently, there are ...
Stocks that moved the previous day part 2: Kyogoku Unyu, GMO Ad Partners, Ise Chemical, ETC.
Stock Name <Code> Closing Price on the 26th ⇒ Change from Previous Day Fuji HD <4676> 1767.5 -91.5 Concern over the ripple effect of magazine articles. Kioxia HD <285A> 1590 -7425 Favorable return selling after significant rebound in recent days. Seed <7743> 551 -36 Continuing the declining trend after recent sharp price increase. Istyle <3660> 448 -19 Pressured by short-term funds' profit-taking selling. Appier Group <4180> 1479 -21 A sense of completion in the rebound.
Emerging Markets Stock Digest: Synbio Pharmaceuticals continues to fall, Business Coach temporarily hits the upper limit.
＜4263＞ Susmed 582 +7 rebound. It was announced that the operation of a clinical trial system (SUSMED SDS) utilizing Blockchain Technology was started in a doctor-led clinical trial at the National Center of Neurology and Psychiatry. This clinical trial targets patients with myalgic encephalomyelitis/chronic fatigue syndrome, aiming to verify the efficacy and safety of Rituximab. Utilizing SUSMED SDS, it aims to reduce monitoring tasks and improve the quality and reliability of the data obtained.
Stocks that moved or were traded in the first half of the session.
*J. Front Retailing <3086> 2150 +1569 - The November period surpassed consensus expectations. *Sekisui Chemical <4204> 2647.5 +193.5 - Reports on the mass production of perovskite Solar Cells have circulated. *Mitsukoshi Isetan <3099> 2696.5 +176.5 - Rising along with J. Front’s favorable Earnings Reports. *Pan Pacific International Holdings <7532> 4250 +231 - European securities have raised the Target Price projections. *Unitika <3103> 148 +7
Strong performance, support for stock prices could be attributed to buying for Dividends, ETC.
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to show a strong performance. The US stock market was closed yesterday, December 25th, due to the Christmas holiday. The major European markets were also closed, leaving few clues, while in the foreign exchange market, the dollar remains at 157.40 yen, continuing to indicate a trend of yen depreciation and dollar strength, providing reassurance in the Tokyo market. Additionally, today is the final trading day for the rights to receive dividends for companies with December fiscal year-end, and buying for dividends and shareholder benefits is expected to support stock prices. Meanwhile, overseas investment